3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
9
Prostatic Neoplasms, Castration-Resistant
1
Pain
1
Neoplasm Metastasis
1
Metastatic Castration-resistant Prostate Cancer (mCRPC)
1
Fatigue
1
Carcinoma, Renal Cell
1
Interventions
enzalutamide
6
radium Ra 223 dichloride
5
Docetaxel
2
Abiraterone Acetate
2
zimberelimab
1
xentuzumab
1
sacituzumab govitecan
1
quemliclustat
1
pembrolizumab
1
atezolizumab
1
apalutamide
1
Standard of Care
1
Radium-223
1
Prednisone
1
Nivolumab
1
Ipilimumab
1
Drug Therapy
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Prostatic Neoplasms, Castration-Resistant
×
Radium-223
×
Clear all
NCT03563014
2020-05-20
BELFIGO
Bayer
Completed
164 enrolled